Ginkgo Bioworks Hldgs Inc (DNA)

$0.28 0.02 (7.62%)

19:00 EDT DNA Stock Quote Delayed 30 Minutes

7 Stocks Most Likely to Follow in WeWork’s Woeful Footsteps

By Alex Sirois, InvestorPlace Contributor Nov 15, 2023

These troubled stocks to sell look even worse following WeWork's bankruptcy and will only hurt holders the longer they hold on.

3 Cutting-Edge Biotech Stocks for the Bold Investor

7 Healthcare Stocks That Are Poised to Become the Next Unicorns

3 Biotech Stocks Ready to Break Out in 2024

Volume:

Previous Close -

Market Cap -

PE Ratio -

EPS -

Volume (Avg. Vol.) 38.33M

Day's Range $0.28 - $0.31

52-Week Range $0.26 - $2.54

Dividend & Yield N/A (N/A)

DNA Stock Predictions, Articles, and Ginkgo Bioworks Hldgs Inc News

3 Promising Cathie Wood Stocks That Will Make Early Investors Rich

By Josh Enomoto, InvestorPlace Contributor Oct 4, 2023

Although the innovation space is getting squirrelly, these Cathie Wood stocks to make you rich provide compelling narratives.

DNA Stock Alert: Ginkgo Bioworks Announces Major Partnership With Pfizer

By Dana Blankenhorn, InvestorPlace Contributor Sep 27, 2023

The deal keeps Ginkgo alive, but its business model of becoming the "Apple Store of Biotech" remains unproven. DNA stock jumped overnight.

Cathie Wood’s Stock Shuffle: 4 Names She’s Loving, 3 She’s Leaving

By Rich Duprey, InvestorPlace Contributor Sep 27, 2023

Investors tend to closely watch which Cathie Wood stocks are bought and sold as she has history of generating big returns in her ETFs.

Immunomics Stocks: 3 Ways to Play This Massive AI-Biotech Megatrend

By John Blankenhorn, InvestorPlace Contributor Sep 22, 2023

Ginkgo Bioworks, Recursion Pharmaceutical, and Eli Lilly are cashing in on the AI-Biotech trend of tomorrow using the big data of today.

The 7 Most Undervalued Cathie Wood Stocks to Buy in September 2023

By Muslim Farooque, InvestorPlace Contributor Sep 15, 2023

Elevate your portfolio with these Cathie Wood's undervalued stocks brimming with robust long-term growth potential

DNA Stock Alert: Did Ginkgo Bioworks Just Become the Next Big AI Stock?

By Chris MacDonald, InvestorPlace Contributor Aug 29, 2023

A key announcement is driving shares of DNA stock more than 20% higher today. Ginkgo Bioworks is making waves in the AI world.

The GMO Frontier: 3 Synthetic Biology Stocks for Your Must-Buy List

By John Blankenhorn, InvestorPlace Contributor Aug 25, 2023

The industries of the future are already available for investing today. Don't get left behind as synthetic biology stocks build the future.

3 Growth Stocks Cathie Wood Is Betting On Now: August 2023

By Yiannis Zourmpanos, InvestorPlace Contributor Aug 4, 2023

Are you looking to invest in the long-term stocks? Here are three growth stocks Cathie Wood is betting on now.

7 Healthcare Stocks to Ditch Before They Make Your Portfolio Sick

By Louis Navellier and the InvestorPlace Research Staff Jul 31, 2023

For investors who choose wisely, profits in healthcare stocks can be spectacular. But the losses can also be dramatic if you choose poorly.

DNA Stock Alert: The $18 Milion Reason Ginkgo Bioworks Is Up Today

By William White, InvestorPlace Writer Jul 19, 2023

Ginkgo Bioworks (DNA) stock is rising higher on Wednesday after the company won a four-year, $18 million contract from DARPA.

Why These 3 Stocks Are the Worst Ways to Play Biotech Right Now

By Ian Bezek, InvestorPlace Contributor Jul 13, 2023

These three dangerous biotech stocks are not investable even if you're bullish on the sector overall.

DNA Stock Alert: Ginkgo Bioworks Moves Forward With Novo Nordisk Partnership

By William White, InvestorPlace Writer Jul 11, 2023

Ginkgo Bioworks (DNA) stock is on the move Tuesday after the company announced a continued partnership with Novo Nordisk.

Hero or Zero? 3 High-Risk Biotech Stocks to Make You Rich … or Broke.

By John Blankenhorn, InvestorPlace Contributor May 22, 2023

These biotech companies are swinging for the fences. They may hit homers, they may strike out. But you'll definitely want to watch them.

DNA Stock Earnings: Ginkgo Bioworks Misses EPS, Beats Revenue Estimates

By Sarah Smith, Editor-in-Chief, InvestorPlace.com May 10, 2023

DNA stock earnings show Ginkgo Bioworks missing analyst estimates for its loss per share but beating revenue estimates.

7 Best Cathie Wood Stocks for Your May 2023 Buy List

By Alex Sirois, InvestorPlace Contributor May 2, 2023

This year promises to be very different for Cathie Wood stocks, as signs of economic improvement become more prominent.

5 Penny Stocks With Explosive 5X Potential

By Thomas Yeung, CFA, InvestorPlace Markets Analyst Apr 17, 2023

Penny stocks are inherently risky, but investing in low-priced companies with wide "moats" can shift the odds in investors' favor.

3 Growth Stocks to Buy for 100% Returns

By Alex Sirois, InvestorPlace Contributor Apr 11, 2023

These three growth stocks to buy could provide triple-digit percentage returns for investors in the near to mid term.

7 Penny Stocks With Massive Growth Potential

By Josh Enomoto, InvestorPlace Contributor Mar 20, 2023

While the market fallout from the banking sector crisis imposes high risks, extreme gamblers may target these enticing penny stocks.

The Next Big Disruptors? 3 Biotech Stocks Making Headlines.

By John Blankenhorn, InvestorPlace Contributor Feb 17, 2023

Biotech stocks were hard-hit in 2022, but these disruptive names in the field of synthetic biology can be big winners in 2023.

3 Penny Stocks That Could Rise 500% in 2023

By Thomas Yeung, CFA, InvestorPlace Markets Analyst Jan 13, 2023

Tilt the odds in your favor in 2023 with some of these high-potential penny stocks. The risks are high, but so are the rewards.

Ginkgo Bioworks Hldgs Inc (DNA)

7 Stocks Most Likely to Follow in WeWork’s Woeful Footsteps

3 Cutting-Edge Biotech Stocks for the Bold Investor

7 Healthcare Stocks That Are Poised to Become the Next Unicorns

3 Biotech Stocks Ready to Break Out in 2024

Top 5 Stocks for 2024

Louis Navellier's Total Grade

Is ? a BUY?

Louis Navellier's Total Grade

Louis Navellier's Total Grade

Fundamental Grade

Quantitative Grade

Ginkgo Bioworks Hldgs Inc (DNA)

Top 5 Stocks for 2024

Louis Navellier's Total Grade

Is ? a BUY?

Louis Navellier's Total Grade

Louis Navellier's Total Grade

Fundamental Grade

Quantitative Grade

DNA Stock Predictions, Articles, and Ginkgo Bioworks Hldgs Inc News

Subscriber Sign in